Alnylam Pharmaceuticals (ALNY) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Alnylam Pharmaceuticals (ALNY) over the last 14 years, with Q4 2025 value amounting to $606.6 million.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments rose 793.15% to $606.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $606.6 million, marking a year-over-year increase of 793.15%. This contributed to the annual value of $606.6 million for FY2025, which is 793.15% up from last year.
- Latest data reveals that Alnylam Pharmaceuticals reported Other Gross PP&E Adjustments of $606.6 million as of Q4 2025, which was up 793.15% from -$191.4 million recorded in Q3 2025.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $606.6 million during Q4 2025, with a 5-year trough of -$238.1 million in Q2 2021.
- In the last 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$197.8 million in 2024 and averaged -$31.5 million.
- Examining YoY changes over the last 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments showed a top increase of 2418.66% in 2021 and a maximum decrease of 720.04% in 2021.
- Over the past 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $392.9 million in 2021, then increased by 17.57% to $462.0 million in 2022, then grew by 14.35% to $528.2 million in 2023, then increased by 6.39% to $562.0 million in 2024, then grew by 7.93% to $606.6 million in 2025.
- Its last three reported values are $606.6 million in Q4 2025, -$191.4 million for Q3 2025, and -$192.4 million during Q2 2025.